BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16493331)

  • 1. [Antinuclear antibodies].
    Goulvestre C
    Presse Med; 2006 Feb; 35(2 Pt 2):287-95. PubMed ID: 16493331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of anti-ENA autoantibodies in patients with systemic connective tissue diseases. Analytical variability and diagnostic sensitivity of 4 methods].
    Villalta D; Bizzaro N; Tonutti E; Visentin D; Manoni F; Piazza A; Toffolo L; Rizzotti P; Clemen P; Pradella M; Bassetti D; Tozzoli R
    Recenti Prog Med; 1999 Nov; 90(11):579-84. PubMed ID: 10608146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antinuclear autoantibodies].
    Röther E; Peter HH
    Internist (Berl); 1995 Mar; 36(3):277-81. PubMed ID: 7737821
    [No Abstract]   [Full Text] [Related]  

  • 4. [Differentiation of autoantibodies to extractable nuclear antigens using immunoblotting in various collagen diseases].
    Riemekasten G; Hiepe F
    Z Arztl Fortbild (Jena); 1992 Mar; 86(5):217-22. PubMed ID: 1585674
    [No Abstract]   [Full Text] [Related]  

  • 5. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology.
    Tan EM
    Adv Immunol; 1989; 44():93-151. PubMed ID: 2646863
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
    Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
    Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence and diagnostic value of antinuclear antibodies without identified antigenic target: a retrospective study of 90 patients].
    Feki S; Frikha F; Ben Hadj Hmida Y; Abed S; Ben Ayed M; Turki H; Hachicha J; Baklouti S; Bahloul Z; Masmoudi H
    Rev Med Interne; 2012 Sep; 33(9):475-81. PubMed ID: 22658165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staining of antinuclear antibodies and antibodies against removable nuclear antigens in connective tissue diseases.
    Oliva Menacho JE; Arroyo-Acevedo JL; Oliva-Candela JA; García-Hjarles MA; Domínguez-Huarcaya L
    Allergol Immunopathol (Madr); 2020; 48(1):18-25. PubMed ID: 31623944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-SL-Ki antibody in a patient with fatal connective tissue overlap disease.
    Parodi A; Nigro A; Rebora A
    Br J Dermatol; 1989 Aug; 121(2):243-6. PubMed ID: 2789073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of antinuclear antibodies in the diagnosis of connective tissue diseases].
    Bambara LM; Biasi D; Caramaschi P; Codella O; Corrocher R; Serpelloni G; De Sandre G
    Recenti Prog Med; 1985 Feb; 76(2):102-9. PubMed ID: 3887516
    [No Abstract]   [Full Text] [Related]  

  • 11. An autoimmune myositis-overlap syndrome associated with autoantibodies to nuclear pore complexes: description and long-term follow-up of the anti-Nup syndrome.
    Senécal JL; Isabelle C; Fritzler MJ; Targoff IN; Goldstein R; Gagné M; Raynauld JP; Joyal F; Troyanov Y; Dabauvalle MC
    Medicine (Baltimore); 2014 Nov; 93(24):383-394. PubMed ID: 25500708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antinuclear antibodies in systemic autoimmune disease].
    Rösken GHJ; van Beek AA; Bakker-Jonges LE; Schreurs MWJ
    Ned Tijdschr Geneeskd; 2020 Apr; 164():. PubMed ID: 32324347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical significance of antinuclear antibodies in connective tissue disease.
    Pahor A; Krajnc I; Gorenjak M; Holc I
    Wien Klin Wochenschr; 1998 May; 110(9):338-41. PubMed ID: 9629626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinuclear antibodies in dermatology.
    Heffernan MP; Do JH; Mehta J
    Semin Cutan Med Surg; 2001 Mar; 20(1):2-13. PubMed ID: 11308133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Immunofluorescence pattern of Antinuclear Antibody with Specific Autoantibodies in the Bangladeshi Population.
    Sharmin S; Ahmed S; Abu Saleh A; Rahman F; Choudhury MR; Hassan MM
    Bangladesh Med Res Counc Bull; 2014 Aug; 40(2):74-8. PubMed ID: 26415344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The optimization of techniques complex of serologic diagnostics of connective tissue systemic diseases].
    Lazareva NM; Lapin SV; Mazing AV; Bulgakova TV; Ilivanova EP; Maslianskiĭ AL; Totolian AA
    Klin Lab Diagn; 2011 Dec; (12):12-7. PubMed ID: 22416425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients.
    Franceschini F; Cavazzana I; Generali D; Quinzanini M; Viardi L; Ghirardello A; Doria A; Cattaneo R
    J Rheumatol; 2002 Jul; 29(7):1393-7. PubMed ID: 12136894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against extractable nuclear antigens (ENA) in systemic scleroderma.
    Jabłońska S; Błaszczyk M; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G; Chorzelski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):765-8. PubMed ID: 312085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recently characterised autoantibodies and their clinical significance.
    Sturgess A
    Aust N Z J Med; 1992 Jun; 22(3):279-89. PubMed ID: 1497555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay.
    Op De Beeck K; Vermeersch P; Verschueren P; Westhovens R; Mariën G; Blockmans D; Bossuyt X
    Autoimmun Rev; 2011 Oct; 10(12):801-8. PubMed ID: 21741497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.